InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: hayward post# 112845

Wednesday, 02/20/2013 1:11:29 PM

Wednesday, February 20, 2013 1:11:29 PM

Post# of 345976
The number in the PR, p=0.217, is based on the combined placebo and 1 mg arms from the trial,
even then it is a 60% increase in MOS. My number of 109% increase is the 3mg arm vs the
original control arm with MOS = 5.6 months. The original p-value for the 3mg arm vs placebo was 0.07.
You are confusing the increase in the MOS (number of months) with the statistical significance
of that increase. There was a large increase in the number of months of survival, but it wasn't
statistically significant. I wouldn't worry about it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News